| Title | Claps | Level | Year | L/Y |
|---|---|---|---|---|
|
Global Molecular Effects of Tocilizumab Therapy in Rheumatoid Arthritis Synovium
7 auth. J. Ducreux, P. Durez, C. Galant, A. Nzeusseu Toukap, Benoît den Eynde, F. Houssiau, ...
To investigate the global molecular effects of tocilizumab (TCZ) in comparison with methotrexate (MTX) treatment in synovial biopsy tissue obtained from patients with previously untreated rheumatoid arthritis (RA) before therapy (T0) and 12 weeks af…
To investigate the global molecular effects of tocilizumab (TCZ) in comparison with methotrexate (MTX) treatment in synovial biopsy tissue obtained from patients with previously untreated rheumatoid arthritis (RA) before therapy (T0) and 12 weeks after the initiation of therapy (T12), and to compare the results with previous gene expression data obtained in synovial biopsy tissue from adalimumab (ADA)– and rituximab (RTX)–treated patients with RA.
Published in
Arthritis & Rheumatology
|
11
|
6 | 2014 |
Social Media Posts